Your browser doesn't support javascript.
loading
Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study.
Bidulka, Patrick; O'Neill, Stephen; Basu, Anirban; Wilkinson, Samantha; Silverwood, Richard J; Charlton, Paul; Briggs, Andrew; Adler, Amanda I; Khunti, Kamlesh; Tomlinson, Laurie A; Smeeth, Liam; Douglas, Ian J; Grieve, Richard.
Afiliación
  • Bidulka P; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK patrick.bidulka1@lshtm.ac.uk.
  • O'Neill S; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
  • Basu A; The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, University of Washington School of Pharmacy, Seattle, Washington, USA.
  • Wilkinson S; Personalized Healthcare Data Science, Roche Products Limited, Welwyn Garden City, UK.
  • Silverwood RJ; Centre for Longitudinal Studies, University College London, London, UK.
  • Charlton P; Patient Research Champion Team, National Institute for Health Research, Twickenham, UK.
  • Briggs A; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
  • Adler AI; Diabetes Trials Unit, The Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
  • Khunti K; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Tomlinson LA; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Smeeth L; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Douglas IJ; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Grieve R; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
BMJ Open ; 11(9): e046912, 2021 09 27.
Article en En | MEDLINE | ID: mdl-34580091
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Metformina Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Metformina Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido